Julie Xian,Shridhar Parthasarathy,Sarah M. Ruggiero,Ganna Balagura,Eryn Fitch,Katherine Helbig,Jing Gan,Shiva Ganesan,Michael C. Kaufman,Colin A. Ellis,David Lewis-Smith,Peter Galer,Kristin Cunningham,Margaret O'Brien,Mahgenn Cosico,Kate Baker,Alejandra Darling,Fernanda Veiga de Goes,Christelle M. El Achkar,Jan Henje Doering,Francesca Furia,Angeles Garcia-Cazorla,Elena Gardella,Lisa Geertjens,Courtney Klein,Anna Kolesnik-Taylor,Hanna Lammertse,Jeehun Lee,Alexandra Mackie,Mala Misra-Isrie,Heather Olson,Emma Sexton,Beth Sheidley,Lacey Smith,Luiza Sotero,Hannah Stamberger,Steffen Syrbe,Kim Marie Thalwitzer,Annemiek van Berkel,Mieke van Haelst,Christopher Yuskaitis,Sarah Weckhuysen,Ben Prosser,Charlene Son Rigby,Scott Demarest,Samuel Pierce,Yuehua Zhang,Rikke S. Moller,Hilgo Bruining,Annapurna Poduri,Federico Zara,Matthijs Verhage,Pasquale Striano,Ingo Helbig

Abstract:Disease-causing variants in STXBP1 are among the most common genetic causes of neurodevelopmental disorders. However, the phenotypic spectrum in STXBP1-related disorders is wide and clear correlations between variant type and clinical features have not been observed so far. Here, we harmonized clinical data across 534 individuals with STXBP1-related disorders and analysed 19 973 derived phenotypic terms, including phenotypes of 253 individuals previously unreported in the scientific literature. The overall phenotypic landscape in STXBP1-related disorders is characterized by neurodevelopmental abnormalities in 95% and seizures in 89% of individuals, including focal-onset seizures as the most common seizure type (47%). More than 88% of individuals with STXBP1-related disorders have seizure onset in the first year of life, including neonatal seizure onset in 47%. Individuals with protein-truncating variants and deletions in STXBP1 (n = 261) were almost twice as likely to present with West syndrome and were more phenotypically similar than expected by chance. Five genetic hotspots with recurrent variants were identified in more than 10 individuals, including p.Arg406Cys/His (n = 40), p.Arg292Cys/His/Leu/Pro (n = 30), p.Arg551Cys/Gly/His/Leu (n = 24), p.Pro139Leu (n = 12), and p.Arg190Trp (n = 11). None of the recurrent variants were significantly associated with distinct electroclinical syndromes, single phenotypic features, or showed overall clinical similarity, indicating that the baseline variability in STXBP1-related disorders is too high for discrete phenotypic subgroups to emerge. We then reconstructed the seizure history in 62 individuals with STXBP1-related disorders in detail, retrospectively assigning seizure type and seizure frequency monthly across 4433 time intervals, and retrieved 251 anti-seizure medication prescriptions from the electronic medical records. We demonstrate a dynamic pattern of seizure control and complex interplay with response to specific medications particularly in the first year of life when seizures in STXBP1-related disorders are the most prominent. Adrenocorticotropic hormone and phenobarbital were more likely to initially reduce seizure frequency in infantile spasms and focal seizures compared to other treatment options, while the ketogenic diet was most effective in maintaining seizure freedom. In summary, we demonstrate how the multidimensional spectrum of phenotypic features in STXBP1-related disorders can be assessed using a computational phenotype framework to facilitate the development of future precision-medicine approaches.

ASXL3‐related disorder: Molecular phenotyping and comprehensive review providing insights into disease mechanism

Four heterozygous de novo variants in ASXL3 identified with Bainbridge–Ropers syndrome and further dissecting published genotype–phenotype spectrum

Bainbridge-ropers syndrome caused by loss-of-function variants in ASXL3: Clinical abnormalities, medical imaging features, and gene variation in infancy of case report

[Report of a child with Bainbridge-Ropers syndrome due to a novel variant of ASXL3 gene and a literature review]

An adolescent case of ASXL3-related disorder with delayed onset of feeding difficulty

ASXL1 truncating variants in BOS and myeloid leukemia drive shared disruption of Wnt-signaling pathways but have differential isoform usage of RUNX3

Expansion of the Genotypic and Phenotypic Spectrum of ASH1L-Related Syndromic Neurodevelopmental Disorder

Identification of a Hemizygous Novel Splicing Variant in ATRX Gene: A Case Report and Literature Review.

A Newborn with a Pathogenic Variant in ASXL2 Expanding the Phenotype of SHAPNS: a Case Report and Literature Review

Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency

Novel SNX13 Frameshift Variant in an Individual with Developmental Delay.

Multiomics of Bohring-Opitz syndrome truncating ASXL1 mutations identify canonical and noncanonical Wnt signaling dysregulation

BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations

Comprehensive study of 28 individuals with SIN3A-related disorder underscoring the associated mild cognitive and distinctive facial phenotype

USP27X variants underlying X-linked intellectual disability disrupt protein function via distinct mechanisms

Assessing the Landscape of STXBP1-related Disorders in 534 Individuals

Resolution of SLC6A1 variable expressivity in a multi-generational family using deep clinical phenotyping and Drosophila models

Novel variants in the CLCN4 gene associated with syndromic X-linked intellectual disability

Further description of two individuals with de novo p.(Glu127Lys) missense variant in the ASCL1 gene

Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals

De novo AHDC1 Deletions Identified by Genome Sequencing in Two Individuals with Xia-Gibbs Syndrome